ORGONasdaq United States
Market cap
$239.335 M
$1.86 -22.82%
Close of 7 Aug 2026
Revenue
$564.2M
#1855 by revenue
Earnings
$37.0M
#1686 by earnings
Shares outstanding
128,674,548
Latest filing cover page
P/E ratio
6.5
Cap ÷ net income
Where these numbers come from
Share counts and financials for Organogenesis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.